This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cassidy, W. M.
Right arrow Articles by West, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cassidy, W. M.
Right arrow Articles by West, D. J.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Hepatitis B

PEDIATRICS Vol. 107 No. 4 April 2001, pp. 626-631

A Randomized Trial of Alternative Two- and Three-Dose Hepatitis B Vaccination Regimens in Adolescents: Antibody Responses, Safety, and Immunologic Memory

Received Apr 27, 2000; accepted Aug 14, 2000.

William M. Cassidy*, Barbara WatsonDagger , Virginia A. Ioli§, Karen Williams, Steven Bird§, and David J. West

From the * Department of Medicine, Louisiana State University Health Science Center, Baton Rouge, Louisiana; Dagger  Vaccine Evaluation Center, Albert Einstein Medical Center, Philadelphia, Pennsylvania; § Merck Research Laboratories, West Point, Pennsylvania; and  Department of Pediatrics, Louisiana State University Health Science Center, Baton Rouge, Louisiana.

Objectives.  Hoping to increase hepatitis B (HB) vaccination of adolescents, we did the following: 1) studied if modified regimens of the recombinant HB vaccine, Recombivax HB (2 or 3 doses of 5 or 10 µg given over 4 or 6 months), induce protective anti-hepatitis B surface antibody [anti-HBsAb] levels (>= 10 mIU/mL) comparable to the recommended regimen (5 µg at 0 and 1, and 6 months); 2) measured early antibody response after a single dose; and 3) assessed immunologic memory after 2- and 3-dose regimens.

Design.  One thousand twenty-six adolescents were randomized to 1 of 5 treatment groups (10 µg at 0 and 4 or 0 and 6 months; 5 µg at 0 and 6 or 0, 2, and 4 or 0, 1, and 6 months) in an open trial. Anti-HBsAb was measured in all participants just before and 1 month after the last dose, and at several other times in a subset of vaccinees. Anti-HBsAb response to a booster dose 2 years later was examined to assess immunologic memory in participants vaccinated with 5 µg at 0 and 6 or 0, 1, and 6 months.

Results.  All regimens induced >= 10 mIU/mL of anti-HBs in >= 95% of vaccinees. Geometric mean titers ranged from 674.8 to 3049.4 mIU/mL. Geometric mean titers were higher with regimens using the following: 1) 10 versus 5 µg; 2) 3 versus 2 doses; and 3) vaccination intervals of 6 versus 4 months. After 6 months, 63.8% of vaccinees given one 10-µg dose had >= 10 mIU/mL of anti-HBsAb versus 41.6% after one 5-µg dose. Participants vaccinated with either two or three 5-µg doses retained robust immunologic memory.

Conclusions.  The results of this study show that a 2-dose regimen of Recombivax HB is as immunogenic and induces immunologic memory as effectively as the recommended 3-dose regimen. A regimen of two 10-µg doses may be of significant benefit for vaccinees who are poorly compliant or deviate from the intended vaccination schedule.  Key words:  hepatitis B, vaccination, immunization, adolescents.




This article has been cited by other articles:


Home page
 Sex. Transm. Infect.Home page
K Van Herck, E Leuridan, and P Van Damme
Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance
Sex. Transm. Inf., October 1, 2007; 83(6): 426 - 432.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. R. del Valle, P. Devaux, G. Hodge, N. J. Wegner, M. B. McChesney, and R. Cattaneo
A Vectored Measles Virus Induces Hepatitis B Surface Antigen Antibodies While Protecting Macaques against Measles Virus Challenge
J. Virol., October 1, 2007; 81(19): 10597 - 10605.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. Samandari, A. E. Fiore, S. Negus, J. L. Williams, W. Kuhnert, B. J. McMahon, and B. P. Bell
Differences in Response to a Hepatitis B Vaccine Booster Dose Among Alaskan Children and Adolescents Vaccinated During Infancy
Pediatrics, August 1, 2007; 120(2): e373 - e381.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H. Horton, C. Havenar-Daughton, D. Lee, E. Moore, J. Cao, J. McNevin, T. Andrus, H. Zhu, A. Rubin, T. Zhu, et al.
Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses in HIV Vaccine Trial Participants Who Subsequently Acquire HIV-1 Infection
J. Virol., October 1, 2006; 80(19): 9779 - 9788.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
L A Wallace, J C Bramley, S Ahmed, R Duff, S J Hutchinson, W F Carman, N R E Kitchin, and D J Goldberg
Determinants of universal adolescent hepatitis B vaccine uptake
Arch. Dis. Child., November 1, 2004; 89(11): 1041 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 Pediatr. Rev.Home page
J. A. Hochman and W. F. Balistreri
Chronic Viral Hepatitis: Always Be Current!
Pediatr. Rev., December 1, 2003; 24(12): 399 - 410.
[Full Text] [PDF]

Home page
 NEJMHome page
L. A. Koutsky, K. A. Ault, C. M. Wheeler, D. R. Brown, E. Barr, F. B. Alvarez, L. M. Chiacchierini, K. U. Jansen, and the Proof of Principle Study Investigators
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
N. Engl. J. Med., November 21, 2002; 347(21): 1645 - 1651.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
I. M. Gonzalez, F. M. Averhoff, M. S. Massoudi, H. Yusuf, F. DeStefano, P. Kramarz, J. E. Maher, J. P. Mullooly, C. Chun, R. L. Davis, et al.
Hepatitis B Vaccination Among Adolescents in 3 Large Health Maintenance Organizations
Pediatrics, November 1, 2002; 110(5): 929 - 934.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Nurs.Home page
Other Articles Noted
Evid. Based Nurs., October 1, 2001; 4(4): E1 - 11.
[Full Text] [PDF]

Home page
 PediatricsHome page
H. P. Levaux, W. H. Schonfeld, J. M. Pellissier, W. M. Cassidy, S. K. Sheriff, and C. Fitzsimon
Economic Evaluation of a 2-Dose Hepatitis B Vaccination Regimen for Adolescents
Pediatrics, August 1, 2001; 108(2): 317 - 325.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
G. A. Poland
Adolescent Hepatitis B Immunization: Making It Simpler
Pediatrics, April 1, 2001; 107(4): 771 - 772.
[Full Text]